This proposal will investigate the relationship between metabolism and neuropharmacology of three structurally dissimilar phenothiazine antipsychotic drugs [thioridazine (Mellaril), trifluoperazine (Stelazine), and chlorpromazine (Thorazine)]. The primary goal of the neuropharmacological experiments is to compare the antidopaminergic activity of the parent phenothiazines with their major metabolites. The in vitro techniques to be used include various radioligand binding assays (e.g., with [3H]-spiperone and [3H]-dopamine), and the ability of drugs to affect dopamine-stimulated adenylate cyclase activity. Another in vitro measure to bridge the gap between data from the intact animal vs. that from brain homogenates, are effects of these drugs on pre- and post-synaptic receptors modulating the release of dopamine and acetylcholine from slices of striatum or other regions. In vitro effects on other neurotransmitter systems (e.g., [3H]-QNB or [3H]-WB-4101 binding) will also be examined. In vivo studies will determine the ability of the drug metabolites or their parent compounds to inhibit amphetamine- or apomorphine-induced behaviors (e.g., stereotyped behavior, aggression, and locomotion) and to alter biochemical estimates of the activity of dopamine neurons using neurochemical methods to evaluated DOPAC, HVA, 1-DOPA, etc., as required. Both intracerebroventricular and peripheral routes of drug administration will be used in the in vivo experiments. Finally, the effects of withdrawal from chronic drug administration will be measured to determine if behavioral and neurochemical changes observed are a function of the metabolites formed from the parent compound. These functional and biochemical data relevant to these phenothiazines and their metabolites will be compared to similar studies with a classical non-phenothiazine neuroleptic (haloperidol) and a compound, SCH 23390, purported to be a specific D1 dopamine antagonist. Mechanisms of metabolism will be determined, focusing on two distinct enzyme systems, the flavin-containing monooxygenase (EC1.14.13.8) and cytochrome P450 monooxygenases. The relative role of the P450 and FCM enzymes in the bioformation of pharmacologically active metabolites, and the effects of chronic administration of these drugs on enzyme activity, will be determined. Species differences in enzyme activity will be exploited by using a species (e.g., hamsters) that should produce patterns of metabolites in blood that are similar to humans and unlike rats.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH037404-01A2
Application #
3376190
Study Section
(BPNA)
Project Start
1984-12-01
Project End
1988-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mileson, B E; Lewis, M H; Mailman, R B (1991) Dopamine receptor 'supersensitivity' occurring without receptor up-regulation. Brain Res 561:1-10
Bishop, J E; Mathis, C A; Gerdes, J M et al. (1991) Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors. J Med Chem 34:1612-24
Niedzwiecki, D M; Cubeddu, L X; Mailman, R B (1989) Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum. J Pharmacol Exp Ther 250:117-25
Niedzwiecki, D M; Cubeddu, L X; Mailman, R B (1989) Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine. J Pharmacol Exp Ther 250:126-33
Mailman, R B; Schulz, D W; Kilts, C D et al. (1986) The multiplicity of the D1 dopamine receptor. Adv Exp Med Biol 204:53-72
Rollema, H; Feenstra, M G; Grol, C J et al. (1986) S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects. Naunyn Schmiedebergs Arch Pharmacol 332:338-45
Lewis, M H; Baumeister, A A; McCorkle, D L et al. (1985) A computer-supported method for analyzing behavioral observations: studies with stereotypy. Psychopharmacology (Berl) 85:204-9
Kilts, C D; Dew, K L; Ely, T D et al. (1985) Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr 342:452-7